1. Home
  2. PLUT vs KZR Comparison

PLUT vs KZR Comparison

Compare PLUT & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLUT
  • KZR
  • Stock Information
  • Founded
  • PLUT 2018
  • KZR 2015
  • Country
  • PLUT Hong Kong
  • KZR United States
  • Employees
  • PLUT N/A
  • KZR N/A
  • Industry
  • PLUT
  • KZR Biotechnology: Pharmaceutical Preparations
  • Sector
  • PLUT
  • KZR Health Care
  • Exchange
  • PLUT NYSE
  • KZR Nasdaq
  • Market Cap
  • PLUT 42.9M
  • KZR 44.1M
  • IPO Year
  • PLUT 2025
  • KZR 2018
  • Fundamental
  • Price
  • PLUT $2.55
  • KZR $4.94
  • Analyst Decision
  • PLUT
  • KZR Hold
  • Analyst Count
  • PLUT 0
  • KZR 2
  • Target Price
  • PLUT N/A
  • KZR $9.00
  • AVG Volume (30 Days)
  • PLUT 104.0K
  • KZR 23.9K
  • Earning Date
  • PLUT 01-01-0001
  • KZR 03-25-2025
  • Dividend Yield
  • PLUT N/A
  • KZR N/A
  • EPS Growth
  • PLUT N/A
  • KZR N/A
  • EPS
  • PLUT N/A
  • KZR N/A
  • Revenue
  • PLUT $952,965.00
  • KZR N/A
  • Revenue This Year
  • PLUT N/A
  • KZR N/A
  • Revenue Next Year
  • PLUT N/A
  • KZR N/A
  • P/E Ratio
  • PLUT N/A
  • KZR N/A
  • Revenue Growth
  • PLUT N/A
  • KZR N/A
  • 52 Week Low
  • PLUT $2.26
  • KZR $4.90
  • 52 Week High
  • PLUT $4.22
  • KZR $9.30
  • Technical
  • Relative Strength Index (RSI)
  • PLUT N/A
  • KZR 40.33
  • Support Level
  • PLUT N/A
  • KZR $5.52
  • Resistance Level
  • PLUT N/A
  • KZR $6.37
  • Average True Range (ATR)
  • PLUT 0.00
  • KZR 0.29
  • MACD
  • PLUT 0.00
  • KZR 0.01
  • Stochastic Oscillator
  • PLUT 0.00
  • KZR 9.28

About PLUT PLUTUS FINANCIAL GROUP LIMITED

Plutus Financial Group Ltd provides financial services. It mainly offers (i) securities dealings and brokerage services (ii) margin financing services and (iii) underwriting and placing services.

About KZR Kezar Life Sciences Inc.

Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.

Share on Social Networks: